A reduced sensitivity to the pressor effect of exogenous angiotensin 1 has been observed in dogs with increased levels of endogenous angiotensinlike activity (1) . Patients with secondary hyperaldosteronism, where levels of endogenous angiotensin are thought to be elevated, also have a reduced pressor responsiveness to exogenous angiotensin, but not to l-norepinephrine (2, 3) . A reduced pressor responsiveness to angiotensin might then be expected with renovascular hypertension, which is said to be associated with increased levels of circulating renin and angiotensin (4) .
The pressor responses to exogenous angiotensin and, in some patients, to l-norepinephrine were initially examined in a variety of experimental and pathological situations where the levels of endogenous angiotensin have either been shown or are believed to be altered. Patients with various hypertensive diseases were then studied. The results suggest that the pressor responsiveness to angiotensin may be a useful clinical test for the diagnosis of renovascular hypertension.
Subjects
The clinical data are given in Table I . Normotensive patients (Patients 1 to 18). These were healthy young adults (Patients 1 to 6) or convalescent patients with normal renal and hepatic function (Patients 7 to 18).
Primary aldosteronism (Patients 19 to 22). Three of the four patients had the typical clinical, laboratory, and pathological features of primary aldosteronism. The * Submitted for publication July 29, 1963; accepted December 4, 1963. Presented in part at the Seventeeuth Annual Meeting of the Southern Society for Clinical Research, January 26, 1963, and published as an abstract (Clin. Res. 1963, 11, 55) . This work was supported by grants from the Dallas and Texas Heart Associations and the U. S. Public Health Service. 1 Unless otherwise specified, the term angiotensin is used to designate the active octapeptide, angiotensin II.
fourth was unique in that his hypertension was of a malignant nature, and he had areas of nodular hyperplasia of the adrenal cortex as well as a single adenoma (5) .
Cirrhosis with ascites (Patients 23 to 28). All were chronic alcoholics and were actively accumulating ascites. Although all had derangements of hepatic function, none was acutely ill.
Essential hypertension (Patients 29 to 57) and labile hypertension (Patients 58 and 59). The diagnosis was based on the following criteria: diastolic blood pressure 90 mm Hg or higher after 2 hours of bed rest, the absence of papilledema or rapidly accelerating retinopathy, blood urea nitrogen below 30 mg per 100 ml, and the absence of all known causes of hypertension. The diastolic blood pressure was 120 mm Hg or higher in eight patients.
All 29 patients had normal intravenous pyelograms and urinary 3-methoxy-4-hydroxymandelic acid excretion.
In nine, renal arteriography was done and was normal. Two additional patients (Patients 55 and 56) had intermittent diastolic hypertension, but were studied while normotensive.
Chronic renal disease (Patients 60 to 67). The causes of the chronic renal disease on clinical grounds were: chronic pyelonephritis (Patient 60), arteriolar nephrosclerosis (Patients 61 to 63), chronic glomerulonephritis (Patients 64 to 66), and gouty nephritis (Patient 67). All patients had stable renal insufficiency with blood urea nitrogens above 30 mg per 100 ml for at least 6 months. None had edema or significant salt wastage.
Malignant hypertension (Patients 68 to 82). The patients with malignant hypertension had no known cause for their disease. The diagnosis was based on the presence of accelerating hypertension with diastolic blood pressure levels above 120 mm Hg and bilateral papilledema. Renal nephritis. They were studied in the the patient, the infusion was then changed to one conearly course of the disease while hypertensive and later taining 0.2 /Ag of angiotensin 2 in each ml of 5%yo glucose after complete recovery while normotensive.
in water. This was begun at a rate of 4 to 6 drops per Coarctation of the aorta (Patient 94). The patient minute, with a constant infusion pump. The rate of inwas a 12-year-old boy with postductal coarctation. The fusion was progressively increased every 10 to 15 mininitial study was done preoperatively, the second study utes until either a 20 mm Hg rise in diastolic blood was done 8 days after surgical repair when the blood pressure occurred or a level of 20 mgsg of angiotensin pressure in the arms had fallen to 150/80.
per kg body weight per minute was reached. The "pressor dose" of angiotensin was the amount required to produce a 20 mm Hg rise of the diastolic blood pressure For at least 4 days before the infusion study, all patients received approximately 100 mEq of sodium daily, 2 Hypertensin, Ciba Pharmaceutical Co., Summit, N. J.
and was expressed on the basis of millimicrograms per kilogram body weight per minute. I-Norepinephrine was infused in an identical fashion, either before or after the angiotensin infusion, at a concentration of 2.0 ,ug per ml. The responses to angiotensin and l-norepinephrine were re-examined in certain subjects after the following manipulations: 1) a 15-mEq sodium diet for 4 days, 2) chlorothiazide, 500 mg twice daily for 4 to 7 days, 3) ammonium chloride, 5 g for 2 days, 10 g for 2 days, and then 15 g for 2 days, or 4) within 30 minutes after the intravenous infusion of normal saline, 250 ml in 30 minutes in four normotensive subjects, 250 to 1,000 ml in 1 to 5 hours in 11 subjects previously given chlorothiazide, 250 or 500 ml in 1 or 2 hours in two subjects previously on a 15-mEq sodium diet for 4 days.
To assess the reproducibility of the pressor response to angiotensin, infusions were repeated after 3 After saline infusion. The pressor dose of angiotensin fell in all four normotensive subjects after the intravenous infusion of 250 ml normal saline over a 30-minute interval (Figure 3) . On the other hand, 13 of 15 patients with malignant hypertension were more resistant to the pressor effect of angiotensin than were the normotensive subjects, and 11 did not respond to 20 mjug per kg per minute (Table I and Figure 1 ). All 15 required more angiotensin than did any of the patients with essential hypertension.
As shown in Table I and Figure 1 , the pressor dose of all the patients with renovascular hypertension or with hypertension caused by acute glomerulonephritis or coarctation of the aorta was greater than that of any of the patients with essential hypertension. The difference between the mean pressor dose of the patients with essential hypertension (3.1 ± 1.1 mug per kg per minute) and the patients with renovascular hypertension (8.6 + 2.1 mug per kg per minute) was highly significant (p = < 0.001).
After surgical relief of the hypertension or after recovery from acute glomerulonephritis, less angiotensin was required for a pressor response ( Figure 5 Moreover, the pressor doses in Patients 63 and In all patients in the entire study, there was 64 who had renal insufficiency and normal blood no correlation between the responsiveness to anpressure were similar to those of the normal sub-giotensin and the initial level of blood pressure, jects (Table I) .
the blood urea nitrogen, the serum sodium or Tests were repeated in seven patients with potassium, or the arterial blood pH. Comparison of the pressor doses of angiotensin and l-norepinephrine Four normotensive subjects were studied before and after the administration of chlorothiazide for 4 days. Initially, the mean pressor dose of angiotensin was 6.8 + 1.0 mug per kg per minute, the mean pressor dose of l-norepinephrine, 106 Comparative studies were done on some of the patients described in the preceding sections. As shown in Table IV , the-changes from the level of the normotensive group in the pressor dose of angiotensin were much greater than the changes in the pressor dose of l-norepinephrine in the patients with essential hypertension, malignant hypertension, or cirrhosis. The decrease in the pressor dose of angiotensin in patients with essential hypertension was greater than the decrease of l-norepinephrine. The increase in the pressor dose of angiotensin in patients with malignant hypertension or cirrhosis with ascites was markedly greater than the increase of l-norepinephrine. Patients with renovascular hypertension also required proportionately more angiotensin than l-norepinephrine.
Discussion
A hypothesis for the control of the level of endogenous angiotensin has been proposed (7, 8) . According to this hypothesis, a decrease in effective arterial blood volume produces a decrease in renal arterial pulse pressure or the degree of stretch within the renal afferent arteriole and thereby stimulates the juxtaglomerular apparatus to secrete renin. Renin causes the release of angiotensin, which stimulates the secretion of aldosterone from the adrenal cortex. This in turn increases the renal tubular reabsorption of sodium, thereby increasing the blood volume and the blood flow to the kidney, resulting in an increase in the stretch within the renal afferent arterioles. The release of renin from the juxtaglomerular apparatus is dampened, and the level of circulating angiotensin decreases. This hypothesis implies that changes in the level of endogenous, circulating renin are reflected by changes in the level of endogenous angiotensin (9) , and the two terms may, in this sense, be used interchangeably.
The plasma levels of renin have been shown to be decreased in subjects on a high salt diet and increased in subjects on a low salt diet (10 The results of the initial part of this study suggest that the degree of responsiveness to the pressor effect of exogenous angiotensin may at least in part reflect the level of endogenous renin and angiotensin. In patients whose effective arterial blood volume is expanded because of primary aldosteronism or the rapid infusion of saline and who should, therefore, have low levels of endogenous angiotensin, little angiotensin was required for a pressor response. In patients whose effective arterial blood volume is shrunken because of the rapid accumulation of ascites, the deprivation of dietary sodium, or a diuresis induced with chlorothiazide, and who should, therefore, have high levels of endogenous angiotensin, more angiotensin was required for a pressor response.
These changes with angiotensin were in general qualitatively similar to but quantitatively more impressive than those observed with i-norepinephrine. If these changes were related entirely to nonspecific variations in responsiveness to all pressor agents, the changes might still be quantitatively different. However, the much more striking variations in responsiveness to angiotensin in various situations where endogenous levels of angiotensin are altered suggest that the pressor response to angiotensin may actually reflect endogenous levels of renin and angiotensin.
Changes in responsiveness to i-norepinephrine similar to those observed in this study have been observed after intake of chlorothiazide (11) , salt deprivation (12), saline infusion (11) , and in hypertension, both essential, in man (13) , and renovascular, in animals (14) . But the greater changes observed with angiotensin may reflect more than these presumably nonspecific alterations. Perhaps the decreased responsiveness to angiotensin in patients with presumably increased endogenous levels of renin and angiotensin is comparable to that noted in animals after repeated administration (15) or with experimentally induced elevations (16) of these substances. In keeping with the observation that patients with renovascular hypertension are less sensitive to angiotensin but are as sensitive to l-norepinephrine as are patients with essential hypertension is the experimental evidence that after the administration of renin the pressor response to renin or angiotension is blunted, but the pressor response to l-norepinephrine is not (17, 18) .
This indirect evidence, of course, does not prove that the pressor response to antiotensin is a reliable estimate of the level of endogenous angiotensin, particularly in patients with essential hypertension. Their increased sensitivity to angiotensin is similar to that noted for various pressor substances (19) and may be related to the decreased size of the vascular lumen (20) or the higher initial blood pressure (21) .
Nonetheless, this heightened sensitivity to the pressor effect of angiotensin in patients with essential hypertension or hypertension associated with chronic renal disease is to be contrasted with the decreased sensitivity in most patients with malignant hypertension or renovascular hypertension. In patients with malignant hypertension, the lessened responsiveness is not simply a reflection of the height of the blood pressure or the presence of renal insufficiency, since patients with equally high blood pressure or equally severe renal insufficiency who did not have malignant hypertension had an increased responsiveness. This decreased sensitivity may reflect high endogenous levels of angiotensin, since the renal ischemia that occurs as a consequence of the necrotizing arteriosclerosis of malignant hypertension should be a continuous stimulus to the release of renin and the maintenance of high levels of circulating angiotensin. Elevated levels have been demonstrated in such patients (22) .
A similar mechanism may explain the lessened sensitivity to exogenous angiotensin noted in patients with renovascular hypertension, all of whom required a greater amount of angiotensin to induce a pressor response than did any of the patients with essential hypertension. Only one of the nine patients with renal arterial narrowing had malignant or rapidly accelerating hypertension, so that the insensitivity to angiotensin cannot be due to the consequences of the hypertension per se. Increased levels of circulating angiotensin would be expected in these patients if the narrowing of the renal artery caused a decreased stretch within the afferent arterioles and, thereby, a continuous stimulus to the release of renin. Increased levels of renin and angiotensin have been found in both animals (4) and humans (23) with renovascular hypertension.
In comparison with patients with essential hypertension or hypertension in association with chronic renal disease, an increased amount of angiotensin II was also needed to induce a pressor response in the two patients with hypertension in the active phase of acute glomerulonephritis and in the one patient with coarctation of the aorta. Increased levels of endogenous angiotensin may be present in patients with these diseases. The glomerular injury of acute nephritis may also involve the juxtaglomerular apparatus and cause the release of increased amounts of renin. With coarctation, the stretch within the renal arterioles may be decreased. The infusion of angiotensin was repeated after relief of the hypertension and the removal of the cause of the presumably increased levels of circulating angiotensin II in patients with these latter three diseases, by surgery in the cases of renovascular hypertension and coarctation, and by healing of the active lesion in acute glomerulonephritis. In all instances the amount of angiotensin required to induce a pressor response fell. This further supports the assumption that the sensitivity to exogenous angiotensin may reflect the level of circulating endogenous angiotensin.
Regardless of the true relationship of the pressor response to exogenous angiotensin to the actual level of endogenous angiotensin, the results of our study suggest that this simple procedure may have clinical usefulness. If the separation between essential hypertension, hypertension due to chronic renal disease, and primary aldosteronism on the one hand, and renovascular hypertension on the other, is upheld with a larger group of patients, the procedure may be a rapid screening test for the differential diagnosis of these diseases. Even so, the procedure as here described would not identify those patients with malignant hypertension who have remediable lesions, since most patients with malignant hypertension from whatever cause will probably have a decreased responsiveness.
Summary
The sensitivity to the pressor action of synthetic angiotensin has been measured in humans under a variety of experimental and pathological conditions where the levels of endogenous angiotensin have either been shown or are presumed to be altered. The studies demonstrate that subjects with presumably low levels of endogenous angiotensin are more sensitive to the pressor effect of exogenous angiotensin; subjects with presumably high levels are less sensitive. The changes in sensitivity to angiotensin are greater than to l-norepinephrine.
Patients with malignant or renovascular hypertension are less sensitive to the pressor effect of angiotensin than are patients with essential hypertension, hypertension associated with chronic renal parenchymal disease, or primary aldosteronism. This simple procedure may have clinical usefulness in the differential diagnosis of renovascular hypertension.
